The global hydrogel-based drug delivery system market size was US$ 6,415 million in 2021. The global hydrogel-based drug delivery system market size is forecast to reach US$ 12,357 million by 2030, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period from 2022 to 2030.
Several medical specialties, including cardiology, cancer, immunology, wound healing, and pain management, has embraced hydrogels as drug delivery systems because they are aesthetically pleasing. Massive amounts of water and a cross-linked polymer network make up hydrogels. Drug administration by hydrogels has been demonstrated to have therapeutic benefits in clinical settings. Small-molecule capsules, macromolecular capsules, and cells, among other therapeutic agents, can release from hydrogels under precise temporal and geographic control. Hydrogels can also cover up the bitter taste and odor of medications. Because of this, hydrogels offer a great deal of potential for use through injection, oral, nasal, buccal, rectal, vaginal, ocular, and other treatment routes.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a positive impact on the global market. Many clinical trials for vaccines require hydrogen, which has driven the market's growth. Additionally, many pharmaceutical companies use hydrogel extensively in their research for various clinical investigations and the creation of novel drugs. This has raised market demand for hydrogel-based drug delivery systems, opening up new potential opportunities for the global market throughout the course of the projection period.
Regional Analysis
North America garnered a significant market share in 2021 and is forecast to have significant growth during the forecast period. As a result of the existence of local hydrogel suppliers, regular product launches, and the existence of cost-effective repayment that contains the cost of modern therapies. In addition, the rising number of studies to improve hydrogel-based protein delivery and growing expenditure on hydrogel-based drug delivery systems. Thus, these factors boost the market growth in the region.
The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the growing adoption of hydrogel-based systems for effective drug delivery processes.
Leading Competitors
The leading prominent companies profiled in the global hydrogel-based drug delivery system market are:
Scope of the Report
The global hydrogel-based drug delivery system market segmentation focuses on Polymer Origin, Delivery Route, and Region.
Segmentation based on Polymer Origin
Segmentation based on Delivery Route
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL HYDROGEN-BASED DRUG DELIVERY SYSTEM MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL HYDROGEN-BASED DRUG DELIVERY SYSTEM MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL HYDROGEN-BASED DRUG DELIVERY SYSTEM MARKET, BY POLYMER ORIGIN
5.1 OVERVIEW
5.2 NATURAL
5.3 HYBRID
5.4 SYNTHETIC
6 GLOBAL HYDROGEN-BASED DRUG DELIVERY SYSTEM MARKET, BY DELIVERY ROUTE
6.1 OVERVIEW
6.2 SUBCUTANEOUS
6.3 ORAL CAVITY
6.4 OCULAR
6.5 TOPICAL
6.6 OTHERS
7 GLOBAL HYDROGEN-BASED DRUG DELIVERY SYSTEM MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL HYDROGEN-BASED DRUG DELIVERY SYSTEM MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
9 COMPANY PROFILES
9.1 ASHLAND
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.2 BAUSCH AND LOMB
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.3 JOHNSON & JOHNSON
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.4 MICROPORE TECHNOLOGIES
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.5 MEDTRONIC
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.6 NEURELIS, INCORPORATED
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.7 OCULAR THERAPEUTIX, INCORPORATED
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.8 PROLYNX INCORPORATED
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.9 PFIZER, INCORPORATED
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.10 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved